Antengene Investor Presentation 2024

Antengene Corporation Limited investor presentation from April 2024 outlining the company's pharmaceutical drug development efforts and clinical trial programs. The presentation covers investigational drug candidates and commercialization efforts focused on treating patients beyond borders.